| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| ATC: | L03AX03 |
| UNII: | 8VJE55B0VG |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Urinary Bladder Neoplasms | 3 | D001749 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Respiratory Tract Diseases | 3 | D012140 | ClinicalTrials |
| Urinary Bladder Neoplasms | 3 | D001749 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Infections | 2 | D007239 | ClinicalTrials |
| HIV Infections | 2 | D015658 | ClinicalTrials |
| Tuberculosis | 2 | D014376 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Sepsis | 2 | D018805 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Sarcoma | 1 | D012509 | ClinicalTrials |
| Neuroblastoma | 1 | D009447 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108905 |
| FDA SRS | 8VJE55B0VG |
CONTENTS